128 related articles for article (PubMed ID: 36638354)
21. Second-line therapies in advanced biliary tract cancers.
Tella SH; Kommalapati A; Borad MJ; Mahipal A
Lancet Oncol; 2020 Jan; 21(1):e29-e41. PubMed ID: 31908303
[TBL] [Abstract][Full Text] [Related]
22. [Adenomatous polyp of the common bile duct; benign tumors of the bile ducts].
ALTHABE A; POGGI DA; FLACHSLAND SIBURU EH
Bol Trab Acad Argent Cir; 1949 Jul; 33(12):380-92. PubMed ID: 18139078
[No Abstract] [Full Text] [Related]
23. Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials.
Nara S; Esaki M; Ban D; Takamoto T; Shimada K; Ioka T; Okusaka T; Ishii H; Furuse J
Jpn J Clin Oncol; 2020 Dec; 50(12):1353-1363. PubMed ID: 33037430
[TBL] [Abstract][Full Text] [Related]
24. Biliary carcinogenesis in pancreaticobiliary maljunction.
Kamisawa T; Kuruma S; Chiba K; Tabata T; Koizumi S; Kikuyama M
J Gastroenterol; 2017 Feb; 52(2):158-163. PubMed ID: 27704265
[TBL] [Abstract][Full Text] [Related]
25. Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
Furuse J; Okusaka T; Funakoshi A; Yamao K; Nagase M; Ishii H; Nakachi K; Ueno H; Ikeda M; Morizane C; Horikawa Y; Mizuno N
Jpn J Clin Oncol; 2006 Sep; 36(9):552-6. PubMed ID: 16887837
[TBL] [Abstract][Full Text] [Related]
26. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
[TBL] [Abstract][Full Text] [Related]
27. Predictive Factors of Chemotherapy Initiation after Biliary Drainage for Advanced Biliary Tract Cancer: A Retrospective Multicenter Study.
Azarfane M; Lièvre A; Senellart H; Dessomme B; Guillouche P; Meyer J; Bennouna J; Wallenhorst T; Salimon M; Gournay J; Matysiak-Budnik T; Lim A; Edeline J; Touchefeu Y
J Gastrointestin Liver Dis; 2021 Jun; 30(2):254-258. PubMed ID: 33951116
[TBL] [Abstract][Full Text] [Related]
28. Intraductal neoplasms of the bile duct. A new challenge to biliary tract tumor pathology.
Nakanuma Y; Uesaka K; Miyayama S; Yamaguchi H; Ohtsuka M
Histol Histopathol; 2017 Oct; 32(10):1001-1015. PubMed ID: 28337739
[TBL] [Abstract][Full Text] [Related]
29. Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme.
Moehler M; Maderer A; Schimanski C; Kanzler S; Denzer U; Kolligs FT; Ebert MP; Distelrath A; Geissler M; Trojan J; Schütz M; Berie L; Sauvigny C; Lammert F; Lohse A; Dollinger MM; Lindig U; Duerr EM; Lubomierski N; Zimmermann S; Wachtlin D; Kaiser AK; Schadmand-Fischer S; Galle PR; Woerns M;
Eur J Cancer; 2014 Dec; 50(18):3125-35. PubMed ID: 25446376
[TBL] [Abstract][Full Text] [Related]
30. Ribonucleotide reductase subunit M1 is a possible chemoresistance marker to gemcitabine in biliary tract carcinoma.
Ohtaka K; Kohya N; Sato K; Kitajima Y; Ide T; Mitsuno M; Miyazaki K
Oncol Rep; 2008 Aug; 20(2):279-86. PubMed ID: 18636187
[TBL] [Abstract][Full Text] [Related]
31. Rising incidence of biliary tract cancers in Shanghai, China.
Hsing AW; Gao YT; Devesa SS; Jin F; Fraumeni JF
Int J Cancer; 1998 Jan; 75(3):368-70. PubMed ID: 9455795
[TBL] [Abstract][Full Text] [Related]
32. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
[TBL] [Abstract][Full Text] [Related]
33. Role of chemotherapy in treatments for biliary tract cancer.
Furuse J; Kasuga A; Takasu A; Kitamura H; Nagashima F
J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):337-41. PubMed ID: 22456744
[TBL] [Abstract][Full Text] [Related]
34. [Biliary tract diseases. Gallbladder and biliary duct cancer].
Vilatobá Chapa M
Rev Gastroenterol Mex; 2010 Aug; 75 Suppl 1():199-201. PubMed ID: 20959250
[No Abstract] [Full Text] [Related]
35. Systemic Treatment for Metastatic Biliary Tract Cancer: State of the Art and a Glimpse to the Future.
Rizzo A; Ricci AD; Cusmai A; Acquafredda S; De Palma G; Brandi G; Palmiotti G
Curr Oncol; 2022 Jan; 29(2):551-564. PubMed ID: 35200550
[TBL] [Abstract][Full Text] [Related]
36. Biliary cystadenoma of the common bile duct with secondary biliary cirrhosis. Report of a case.
Thomsen P; Vasehus Madsen P; Moesgaard F; Lykkegaard Nielsen MC
Acta Med Scand; 1984; 216(3):327-30. PubMed ID: 6496190
[TBL] [Abstract][Full Text] [Related]
37. Cholangiojejunostomy (Longmire operation) for relief of biliary obstruction due to carcinoma.
WADDELL WR; BURBANK CB
N Engl J Med; 1952 Dec; 247(24):929-32. PubMed ID: 13002649
[No Abstract] [Full Text] [Related]
38. Photodynamic therapy for pancreatic and biliary tract cancer: the United Kingdom experience.
Pereira S
J Natl Compr Canc Netw; 2012 Oct; 10 Suppl 2():S48-51. PubMed ID: 23055216
[TBL] [Abstract][Full Text] [Related]
39. Intraductal papillary mucinous neoplasm: a new entity among biliary tract neoplasms.
Merayo-Álvarez M; García Bernardo C; Contreras Saiz E
Rev Esp Enferm Dig; 2021 Mar; 113(3):231. PubMed ID: 33291937
[TBL] [Abstract][Full Text] [Related]
40. [Clinico-pathological conference; biliary carcinoma].
Prensa Med Mex; 1952 May; 17(5):113-6. PubMed ID: 14957779
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
